376 related articles for article (PubMed ID: 31547024)
1. The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).
Mroczko B; Groblewska M; Litman-Zawadzka A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547024
[TBL] [Abstract][Full Text] [Related]
2. Amyloid β oligomers (AβOs) in Alzheimer's disease.
Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
J Neural Transm (Vienna); 2018 Feb; 125(2):177-191. PubMed ID: 29196815
[TBL] [Abstract][Full Text] [Related]
3. Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer's Pathogenesis.
Penke B; Szűcs M; Bogár F
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260279
[TBL] [Abstract][Full Text] [Related]
4. P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease.
Farmer KM; Ghag G; Puangmalai N; Montalbano M; Bhatt N; Kayed R
Acta Neuropathol Commun; 2020 Aug; 8(1):132. PubMed ID: 32778161
[TBL] [Abstract][Full Text] [Related]
5. Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
Wu R; Gu J; Zhou D; Tung YC; Jin N; Chu D; Hu W; Wegiel J; Gong CX; Iqbal K; Liu F
J Alzheimers Dis; 2021; 79(4):1647-1659. PubMed ID: 33459649
[TBL] [Abstract][Full Text] [Related]
6. Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers.
Rudenko LK; Wallrabe H; Periasamy A; Siller KH; Svindrych Z; Seward ME; Best MN; Bloom GS
J Alzheimers Dis; 2019; 71(4):1125-1138. PubMed ID: 31524157
[TBL] [Abstract][Full Text] [Related]
7. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
[TBL] [Abstract][Full Text] [Related]
8. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
9. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid from Alzheimer's disease patients promotes tau aggregation in transgenic mice.
Skachokova Z; Martinisi A; Flach M; Sprenger F; Naegelin Y; Steiner-Monard V; Sollberger M; Monsch AU; Goedert M; Tolnay M; Winkler DT
Acta Neuropathol Commun; 2019 May; 7(1):72. PubMed ID: 31064413
[TBL] [Abstract][Full Text] [Related]
11. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
12. Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons.
Hallinan GI; Vargas-Caballero M; West J; Deinhardt K
J Neurosci; 2019 Nov; 39(48):9623-9632. PubMed ID: 31658988
[TBL] [Abstract][Full Text] [Related]
13. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
[TBL] [Abstract][Full Text] [Related]
14. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
[TBL] [Abstract][Full Text] [Related]
16. Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease.
Velickaite V; Giedraitis V; Ström K; Alafuzoff I; Zetterberg H; Lannfelt L; Kilander L; Larsson EM; Ingelsson M
BMC Geriatr; 2017 Sep; 17(1):208. PubMed ID: 28886705
[TBL] [Abstract][Full Text] [Related]
17. The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios.
Wobst HJ; Sharma A; Diamond MI; Wanker EE; Bieschke J
FEBS Lett; 2015 Jan; 589(1):77-83. PubMed ID: 25436420
[TBL] [Abstract][Full Text] [Related]
18. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
[TBL] [Abstract][Full Text] [Related]
19. Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease.
Tai HC; Wang BY; Serrano-Pozo A; Frosch MP; Spires-Jones TL; Hyman BT
Acta Neuropathol Commun; 2014 Oct; 2():146. PubMed ID: 25330988
[TBL] [Abstract][Full Text] [Related]
20. Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease.
Chatterjee M; Del Campo M; Morrema THJ; de Waal M; van der Flier WM; Hoozemans JJM; Teunissen CE
Alzheimers Res Ther; 2018 Jun; 10(1):52. PubMed ID: 29859129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
